In this episode, Andie and Anthony break down PointClickCare Life Sciences’ Commercial Dataset and how it helps teams understand the long-term care market, identify therapy opportunities, and measure commercial performance with recent, real-world data.They explore what makes the dataset unique, how market and orders views support different commercial questions, and why one-week data latency matters for teams working across long-term and post-acute care.

In this episode, Andie Cartwright and Anthony Pero unpack a new real-world EHR study on depression pharmacotherapy in long-term care. They explore how often residents with depression receive treatment, which medication classes are most common, and what the data reveal about disparities tied to race, comorbidities, and facility context.The conversation also looks at what these findings mean for screening, equitable prescribing, and strengthening depression care in socially vulnerable settings.

In recognition of National Kidney Month, Andie Cartwright and Anthony Pero explore chronic kidney disease through two critical lenses: the human impact on aging and vulnerable populations, and the role of real-world data in improving earlier identification, care planning, and outcomes.The episode examines how CKD often progresses silently, why older adults and historically underserved communities face disproportionate risk, and how better visibility across care settings can support more timely intervention. Drawing on current public-health context and the CKD brochure referenced for this episode, the conversation also highlights how datasets and longitudinal insights can help researchers, providers, and life sciences teams better understand disease burden and opportunities for action.National Kidney Month context and the urgency of CKD awarenessKey prevalence, awareness, and disparity trends in chronic kidney diseaseHow real-world data can inform research, risk stratification, and care decisions

Andie and Anthony explore the evolving use of medications in dementia care within long-term facilities, uncovering who benefits from treatment through a massive EHR study. The episode highlights demographic disparities, clinical challenges, and how real-world data can shape future policies to improve quality of life for those with ADRD.

In this episode, Andie and Anthony explore the surprising gaps in diabetes treatment among long-term care residents, revealing racial and regional disparities impacting medication access. Discover how real-world data is driving change to improve outcomes for vulnerable seniors.

Andie and Anthony explore the high rates of depression in long-term care and the disparities in treatment access revealed by real-world data. The episode highlights the urgent need for personalized approaches and trust-building to improve care for vulnerable populations.

Andie and Anthony explore the surprising under-treatment of hyperlipidemia in long-term care residents and the social disparities that influence care. Discover how data-driven insights and clinical leadership can improve guideline adherence and enhance cardiovascular outcomes for vulnerable populations.

This episode explores how COVID-19 changed hypertension management in nursing homes, especially among residents with dementia. Hear insights on deprescribing challenges, balancing medication risks, and innovative protocols to improve quality of life in vulnerable populations.

Explore how treatment patterns vary among long-term care residents with dementia, uncovering disparities influenced by demographics and clinical factors. This episode highlights challenges like polypharmacy and the urgent need for new therapies, drawing on real-world insights to improve quality of life for vulnerable populations.

Explore groundbreaking research linking the herpes zoster vaccine to reduced dementia risk in nursing home residents. Dive into how advanced data methods validate these findings and discuss the critical need to improve vaccine uptake among vulnerable populations for better health outcomes.